JohnE.ErvinMDF.A.C.P., F.A.C.R.
Rheumatology • Kansas City, MOCEO, Medical Director, and Principal Investigator at The Center for Pharmaceutical Research
Dr. Ervin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1010 Carondelet Dr
Suite 426
Kansas City, MO 64114Phone+1 816-943-1292Fax+1 816-268-6976
Summary
- Dr. John E. Ervin earned his undergraduate degree at the University of Notre Dame and received his medical degree from the University of Kansas School of Medicine in 1976.
There he completed a Residency in Internal Medicine and a Fellowship in Allergy, Immunology, and Rheumatology. He is board-certified in both Internal Medicine and Rheumatology. In addition, Dr. Ervin has been on the teaching staff at both the University of Kansas Medical Center and the University of Missouri -- Kansas City.
John E. Ervin, M.D., F.A.C.P., F.A.C.R. founded The Center for Pharmaceutical Research in 1986, and serves as the CEO, Medical Director, and Principal Investigator. He was the first president and co-founder of The Society of Principal Investigators and is a founding member of The Alliance for Multispecialty Research. He has conducted over 800 phase I through IV clinical trials.
Education & Training
University of Kansas School of MedicineInternship, Internal Medicine, 1975 - 1976- University of Kansas School of MedicineResidency, Allergy and Immunology, 1974 - 1976
- University of Kansas School of MedicineResidency, Internal Medicine, 1974 - 1974
- University of Kansas School of MedicineClass of 1974
Certifications & Licensure
MO State Medical License 1976 - 2025
KS State Medical License 1975 - 2023- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- • “America's Top Physicians 2010" - Consumer Research Council of America
- The Best Physicians in 27 Specialties, Kansas City 2003,2007,2008 BEST DOCTORS as chosen by their peers
- • Fellow American College of Physicians (FACP)
- Join now to see all
Clinical Trials
- Evaluate the Safety and Immunogenicity of a Seasonal Influenza VLP Vaccine (Recombinant) in Healthy Adults Start of enrollment: 2008 Sep 01
- Clinical Trial for Evaluation of Vermillion's Blood Test to Predict the Probability of Peripheral Artery Disease Start of enrollment: 2011 Mar 01
- The Plecanatide Chronic Idiopathic Constipation (CIC) Study Start of enrollment: 2011 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsAdipose-Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial.Dinesh Khanna, Paul Caldron, Richard W Martin, Suzanne Kafaja, Robert Spiera
Arthritis & Rheumatology. 2022-08-01 - 21 citationsCivamide cream 0.075% in patients with osteoarthritis of the knee: a 12-week randomized controlled clinical trial with a longterm extensionThomas J. Schnitzer, Jean-Pierre Pelletier, Doug M. Haselwood, William T. Ellison, John E. Ervin
The Journal of Rheumatology. 2012-03-01 - 16 citationsSafety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18-64 years of age.Geoffrey J. Gorse, Ann R. Falsey, Carol M. Johnson, Dennis Morrison, David Fried
Vaccine. 2013-12-05
Press Mentions
You’d Think COVID Gives Smokers a Reason to Quit. In KS and MO, Many Did the OppositeJune 14th, 2021- Inovio’s Recent Data Fails to Impress Some Analysts but Overall Data Looks Promising & Study Backed by Department of DefenseDecember 29th, 2020
- Kansas City Doctor Who Oversaw Clinical Trials Stresses Importance of COVID-19 VaccineDecember 3rd, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
